| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |